MPM is an early-stage life sciences venture investing firm with a track record of identifying and building world-class companies that seek to cure major diseases by translating scientific innovations into positive clinical outcomes. MPM’s diversified and active portfolio of companies aims to revolutionize the face of medicine across multiple areas including cancer, diabetes, obesity, pain, eHealth and more. With its deep experience, dedicated team of operating executives, and distinguished medical and scientific advisory board, MPM is powering novel medical breakthroughs that transform patient lives.